AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 289: E187-E196, 2005; doi:10.1152/ajpendo.00011.2005
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (51)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, L. Q.
Right arrow Articles by Liu, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, L. Q.
Right arrow Articles by Liu, F.

INVITED REVIEWS

PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle

Lily Q. Dong1 and Feng Liu2

1Department of Cellular and Structural Biology, and 2Departments of Pharmacology and Biochemistry, University of Texas Health Science Center, San Antonio, Texas

Activation of members of the protein kinase AGC (cAMP dependent, cGMP dependent, and protein kinase C) family is regulated primarily by phosphorylation at two sites: a conserved threonine residue in the activation loop and a serine/threonine residue in a hydrophobic motif (HM) near the COOH terminus. Although phosphorylation of these kinases in the activation loop has been found to be mediated by phosphoinositide-dependent protein kinase-1 (PDK1), the kinase(s) that catalyzes AGC kinase phosphorylation in the HM remains uncharacterized. So far, at least 10 kinases have been suggested to function as an HM kinase or the so-called "PDK2," including mitogen-activated protein (MAP) kinase-activated protein kinase-2 (MK2), integrin-linked kinase (ILK), p38 MAP kinase, protein kinase C{alpha} (PKC{alpha}), PKC{beta}, the NIMA-related kinase-6 (NEK6), the mammalian target of rapamycin (mTOR), the double-stranded DNA-dependent protein kinase (DNK-PK), and the ataxia telangiectasia mutated (ATM) gene product. However, whether any or all of these kinases act as a physiological HM kinase remains to be established. Nonetheless, available data suggest that multiple systems may be used in cells to regulate the activation of the AGC family kinases. It is possible that, unlike activation loop phosphorylation, phosphorylation of the HM site in the different AGC family kinases is mediated by distinct kinases. In addition, phosphorylation of the AGC family kinase at the HM site could be cell type, signaling pathway, and substrate specific. Identification and characterization of the bonafide HM kinase(s) will be essential to verify these hypotheses.

phosphoinositide-dependent protein kinase-2; phosphoinositide-dependent protein kinase-1; Akt; hydrophobic motif kinase


Address for reprint requests and other correspondence: F. Liu, Depts. of Pharmacology and Biochemistry, Univ. of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229 (e-mail: liuf{at}uthscsa.edu)




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Physiol Rev, January 1, 2009; 89(1): 27 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
N. T. Ihle and G. Powis
Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy
Mol. Cancer Ther., January 1, 2009; 8(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. S. Deepa and L. Q. Dong
APPL1: role in adiponectin signaling and beyond
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E22 - E36.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Nakamura, M. Naito, T. Tsuruo, and N. Fujita
Freud-1/Aki1, a Novel PDK1-Interacting Protein, Functions as a Scaffold To Activate the PDK1/Akt Pathway in Epidermal Growth Factor Signaling
Mol. Cell. Biol., October 1, 2008; 28(19): 5996 - 6009.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Caporali, L. Levati, G. Starace, G. Ragone, E. Bonmassar, E. Alvino, and S. D'Atri
AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition
Mol. Pharmacol., July 1, 2008; 74(1): 173 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Tokuda, N. Fujita, T. Oh-hara, S. Sato, A. Kurata, R. Katayama, T. Itoh, T. Takenawa, K. Miyazono, and T. Tsuruo
Casein Kinase 2 Interacting Protein-1, a Novel Akt Pleckstrin Homology Domain-Interacting Protein, Down-regulates PI3K/Akt Signaling and Suppresses Tumor Growth In vivo
Cancer Res., October 15, 2007; 67(20): 9666 - 9676.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Agouni, C. Sourbier, S. Danilin, S. Rothhut, V. Lindner, D. Jacqmin, J.-J. Helwig, H. Lang, and T. Massfelder
Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B
Carcinogenesis, September 1, 2007; 28(9): 1893 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. J. Khundmiri, V. Amin, J. Henson, J. Lewis, M. Ameen, M. J. Rane, and N. A. Delamere
Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1171 - C1180.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
I. Shiojima and K. Walsh
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Genes & Dev., December 15, 2006; 20(24): 3347 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Guo, A. Sabri, H. Elouardighi, V. Rybin, and S. F. Steinberg
{alpha}1-Adrenergic Receptors Activate AKT via a Pyk2/PDK-1 Pathway That Is Tonically Inhibited by Novel Protein Kinase C Isoforms in Cardiomyocytes
Circ. Res., December 8, 2006; 99(12): 1367 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Barragan, M. de Frias, D. Iglesias-Serret, C. Campas, E. Castano, A. F. Santidrian, L. Coll-Mulet, A. M. Cosialls, A. Domingo, G. Pons, et al.
Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}
J. Leukoc. Biol., December 1, 2006; 80(6): 1473 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Patke, I. Mecklenbrauker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky
BAFF controls B cell metabolic fitness through a PKC{beta}- and Akt-dependent mechanism
J. Exp. Med., October 30, 2006; 203(11): 2551 - 2562.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
F. Fiory, A. T. Alberobello, C. Miele, F. Oriente, I. Esposito, V. Corbo, M. Ruvo, B. Tizzano, T. E. Rasmussen, S. Gammeltoft, et al.
Tyrosine Phosphorylation of Phosphoinositide-Dependent Kinase 1 by the Insulin Receptor Is Necessary for Insulin Metabolic Signaling
Mol. Cell. Biol., December 15, 2005; 25(24): 10803 - 10814.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. C. Hresko and M. Mueckler
mTOR{middle dot}RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes
J. Biol. Chem., December 9, 2005; 280(49): 40406 - 40416.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.